Acumen Pharmaceuticals annual operating expenses
2020
2021
2022
2023
2024
2025
Acumen Pharmaceuticals Operating Expenses Growth & History (ABOS)
Acumen Pharmaceuticals's operating expenses was $123.8M for fiscal 2025.
View full Acumen Pharmaceuticals company overviewAcumen Pharmaceuticals annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $123.8M | $9.8M | +8.61% |
| 2024 | 2024-12-31 | $114.0M | $52.9M | +86.49% |
| 2023 | 2023-12-31 | $61.1M | $15.9M | +35.15% |
| 2022 | 2022-12-31 | $45.2M | $25.7M | +130.99% |
| 2021 | 2021-12-31 | $19.6M | $10.2M | +109.50% |
| 2020 | 2020-12-31 | $9.3M | — | — |
Acumen Pharmaceuticals quarterly operating expenses
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $32.6M | −$9.2M | −22.02% |
| Q1 2026 | 2026-03-31 | $21.1M | −$9.2M | −30.36% |
| Q4 2025 | 2025-12-31 | $25.2M | −$14.4M | −36.36% |
| Q3 2025 | 2025-09-30 | $26.5M | −$5.8M | −17.83% |
| Q2 2025 | 2025-06-30 | $41.8M | $17.4M | +71.24% |
| Q1 2025 | 2025-03-31 | $30.4M | $12.6M | +70.87% |
| Q4 2024 | 2024-12-31 | $39.6M | $21.1M | +114.20% |
| Q3 2024 | 2024-09-30 | $32.3M | $16.2M | +101.17% |
| Q2 2024 | 2024-06-30 | $24.4M | $10.9M | +80.89% |
| Q1 2024 | 2024-03-31 | $17.8M | $4.6M | +35.32% |
| Q4 2023 | 2023-12-31 | $18.5M | $4.2M | +29.74% |
| Q3 2023 | 2023-09-30 | $16.0M | $4.7M | +41.05% |
| Q2 2023 | 2023-06-30 | $13.5M | $3.1M | +29.46% |
| Q1 2023 | 2023-03-31 | $13.1M | $3.9M | +42.68% |
| Q4 2022 | 2022-12-31 | $14.2M | $5.8M | +69.33% |
| Q3 2022 | 2022-09-30 | $11.4M | $7.4M | +188.97% |
| Q2 2022 | 2022-06-30 | $10.4M | $7.0M | +202.56% |
| Q1 2022 | 2022-03-31 | $9.2M | $5.4M | +142.71% |
| Q4 2021 | 2021-12-31 | $8.4M | — | — |
| Q3 2021 | 2021-09-30 | $3.9M | $715,000 | +22.20% |
| Q2 2021 | 2021-06-30 | $3.4M | $1.3M | +57.41% |
| Q1 2021 | 2021-03-31 | $3.8M | — | — |
| Q3 2020 | 2020-09-30 | $3.2M | — | — |
| Q2 2020 | 2020-06-30 | $2.2M | — | — |
Acumen Pharmaceuticals operating expenses trends
Over the last five fiscal years, Acumen Pharmaceuticals's operating expenses increased from $9.3M to $123.8M, a change of $114.5M. The latest reported quarter, Q2 2026, shows $32.6M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Acumen Pharmaceuticals source filings ↗